Menu

gethealthspan

#168 | Mito Boosters: Methylene Blue & Urolithin A | Richard LaFountain, Phd & Brandon Fell, MS

Mitochondrial health is all the rage right now, and frankly I’m a big believer. I’m doing everything I can to improve my mitochondrial health…including taking two of darlings of the internet: methylene blue and urolithin A. As you’ll know from past episodes I’ve had great success with methylene blue despite how crazy taking a synthetic dye into my body regularly sounds to me. More recently, and against all the advice I’ve received from guests on the show, I started taking urolithin A as an experiment…just to see if I could get any benefit…and 2 months in I cannot say it’s been a success. Dang.
The good news is I have the Healthspan guys, Rich and Brandon back for part 2, to explain the Healthspan thinking on these two chemicals they provide to their clients. They walk through lall the whys and hows of the safety and benefits to be had. This was a great chat

Read More

#115 | Winning Athletic Longevity | Dr Rick Cohen & Daniel Tawfik of Healthspan

One of the major bummers for the older athlete, is that no one knows how to make people younger.  All we can do is slow down the rate of aging.  The healthier we are, the slower we age….meaning the more slowly we progress toward that visit to the pearly gates. 

How can we balance risk and reward, prioritize which interventions to pursue first, how to tell is we are getting a positive or negative result from our interventions including pharmaceuticals and nutritional supplements. These are the questions answered by Daniel and Rick.

Read More

#96 — What is Longevity Medicine?…w/ Daniel Tawfik, Co-Founder of Healthspan

According to Healthspan, a normal part of the aging process that we all are going through right now…. we are accumulating more damaged and dysfunctional cells that are unable to carry out their original functions. Some of these cells—senescent cells—go a step further and recruit healthy cells to be dysfunctional as well. Healthspan says the interventions they focus on, which includes rapamycin, metformin, and acarbose, target three areas to prevent, resolve, and reduce the impact of senescent cells

Read More